BDBM50067631 3-(3-{[2-(Benzo[1,3]dioxol-5-yloxy)-ethyl]-methyl-amino}-propyl)-2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-thiazolidin-4-one::CHEMBL107949
SMILES: CN(CCCN1C(SCC1=O)c1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)CCOc1ccc2OCOc2c1
InChI Key: InChIKey=DTCZSWHPFSCCJV-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium channel (RAT) | BDBM50067631 (3-(3-{[2-(Benzo[1,3]dioxol-5-yloxy)-ethyl]-methyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Chugai Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro inhibition of K+ induced contractions of the isolated rat aorta. | J Med Chem 41: 4309-16 (1998) Article DOI: 10.1021/jm980335f BindingDB Entry DOI: 10.7270/Q23N22JV | |||||||||||
More data for this Ligand-Target Pair |